As previously reported, Amgen sought leave to appeal a decision of the Federal Court of Appeal (2020 FCA 188) affirming Justice Southcott's decision that the relevant claims of its filgrastim (NEUPOGEN)

The Supreme Court of Canada has recently denied leave to appeal from the Federal Court of Appeal decision in "Allergan Inc. et al ats. Apotex Inc.".

As previously reported, the Federal Court of Appeal dismissed Apotex's appeal of a decision relating to macitentan (Janssen's OPSUMIT), which found that Apotex would induce infringement of Janssen's patent.

Eli Lilly seeks leave in olanzapine section 8 damages action.

As previously reported, the Federal Court of Appeal (FCA) dismissed Teva's appeal on the quantification of damages from infringement of Janssen's patent for levofloxacin (LEVAQUIN).

On June 30, the Supreme Court of Canada (SCC) delivered its highly anticipated decision, AstraZeneca v Apotex, 2017 SCC 36 relating to esomeprazole (NEXIUM).

Jill Tonus and Nathan Haldane contributed to the Canada chapter in the first edition of The International Comparative Legal Guide to: Copyright 2015.

REVLIMID (lenalidomide): Celgene v Taro.

On the eve of the Sochi Olympics, the Olympic Committees, broadcasters, marketers, and their legal teams, have begun to brace for the next round of ambush marketing.

On February 6, 2017, Mega Byte Information ("Mega Byte") was sentenced by the Court of Québec and fined $450,000 after pleading guilty to operating a deceptive telemarketing scheme...

In February 2012, in Richard v. Time Inc., 2012 SCC 8 the Supreme Court of Canada (the Court) held that a determination that an ad is misleading is based on the general impression a consumer has after initial contact with the entire ad, and relates to the ad’s layout and words used.

Have you ever visited an online store to look at a jacket only to find that ads for that same jacket follow you from site to site?

Canadian courts appear to be signaling greater willingness to award damages for privacy breaches.

In September 2013, Manitoba became the most recent province with privacy legislation governing the collection, use and retention of personal information by private sector entities by passing The Personal Information Protection and Identity Theft Prevention Act (PIPITPA).

The Canadian Radio-television and Telecommunications Commission ("CRTC") investigated the online dating site, Plenty of Fish, following complaints from its registered users about commercial emails...

In September 2011, the Federal Trade Commission in the U.S. (the FTC) sought public comments on proposed changes to its regulation relating to the Children’s Online Privacy Protection Act (COPPA) Regulations.

We now have the first Undertaking involving alleged text message violations of Canada's Anti-Spam Legislation ("affectionately" known as CASL).

Therapeutic antibodies have grown to become an important product class within the biopharmaceutical market.

On January 29, 2026, Canada's Drug Agency (CDA) published Improvements to the Drug Reimbursement Review Process, which includes a section for consultation on proposed changes to the reimbursement review process.

On May 12, 2026, the Patented Medicine Prices Review Board (PMPRB) released its May NEWSLetter. The NEWSletter provides updates on the implementation of the new Guidelines for PMPRB Staff, the consultation of the proposed Hearing Practice Directions, events in which the PMPRB participated, and new and upcoming NPDUIS research publications.